Cleared Traditional

K904739 - DYNAPULSE 200M

K904739 is the FDA 510(k) clearance for DYNAPULSE 200M by Pulse Metric, Inc.. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 82-day FDA review.

K904739 · Pulse Metric, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1991
Decision
82d
Days
Class 2
Risk

K904739 is an FDA 510(k) clearance for the DYNAPULSE 200M. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Pulse Metric, Inc. (San Diego, US). The FDA issued a Cleared decision on January 8, 1991 after a review of 82 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Pulse Metric, Inc. devices

Submission Details

510(k) Number K904739 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 18, 1990
Decision Date January 08, 1991
Days to Decision 82 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
43d faster than avg
Panel avg: 125d · This submission: 82d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 520
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K904739.
CARDIOCAP CMX-104 MONITOR
K903237 · Datex Division Instrumentarium Corp. · Jul 1991
COROMETRICS 5566AAX NONINVASIVE BLOOD PRESSURE MOD
K911310 · Ge Medical Systems Information Technologies · Jun 1991
HP MODEL M1008B, NONINVASIVE BLOOD PRESSURE MODULE
K903771 · Hewlett-Packard Co. · Feb 1991
LOCAL REPORT GENERATOR
K904318 · Spacelabs, Inc. · Dec 1990
FUKUDA DENSHI MODEL HJ-310
K901889 · Fukuda Denshi USA, Inc. · Jul 1990
SUPERMON NEONATAL NON-INVASIVE BLOOD PRESS. 7283
K882955 · Kontron Instruments, Inc. · Jan 1990